Astaxanthin protects astrocytes against trauma-induced apoptosis through inhibition of NKCC1 expression via the NF-κB signaling pathway

[1]  Chunlong Zhong,et al.  Astaxanthin alleviates cerebral edema by modulating NKCC1 and AQP4 expression after traumatic brain injury in mice , 2016, BMC Neuroscience.

[2]  C. Dixon,et al.  Administration of DHA Reduces Endoplasmic Reticulum Stress-Associated Inflammation and Alters Microglial or Macrophage Activation in Traumatic Brain Injury , 2015, ASN neuro.

[3]  Guo-Yuan Yang,et al.  Carvacrol protects neuroblastoma SH-SY5Y cells against Fe2+-induced apoptosis by suppressing activation of MAPK/JNK-NF-κB signaling pathway , 2015, Acta Pharmacologica Sinica.

[4]  Mengliang Zhou,et al.  Astaxanthin Activates Nuclear Factor Erythroid-Related Factor 2 and the Antioxidant Responsive Element (Nrf2-ARE) Pathway in the Brain after Subarachnoid Hemorrhage in Rats and Attenuates Early Brain Injury , 2014, Marine drugs.

[5]  Ji-Xin Shi,et al.  Astaxanthin offers neuroprotection and reduces neuroinflammation in experimental subarachnoid hemorrhage. , 2014, The Journal of surgical research.

[6]  M. Norenberg,et al.  Activation of NF-κB mediates astrocyte swelling and brain edema in traumatic brain injury. , 2014, Journal of neurotrauma.

[7]  Zong Zhuang,et al.  Amelioration of oxidative stress and protection against early brain injury by astaxanthin after experimental subarachnoid hemorrhage. , 2014, Journal of neurosurgery.

[8]  A. Patruno,et al.  Astaxanthin Treatment Confers Protection against Oxidative Stress in U937 Cells Stimulated with Lipopolysaccharide Reducing O2 − Production , 2014, PloS one.

[9]  S. Dübel,et al.  NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseases , 2013, Proceedings of the National Academy of Sciences.

[10]  J. Keyser,et al.  Immune Players in the CNS: The Astrocyte , 2013, Journal of Neuroimmune Pharmacology.

[11]  A. Patruno,et al.  Astaxanthin Treatment Reduced Oxidative Induced Pro-Inflammatory Cytokines Secretion in U937: SHP-1 as a Novel Biological Target , 2012, Marine drugs.

[12]  C. Limatola,et al.  Anomalous levels of Cl− transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex , 2011, Epilepsia.

[13]  G. Sieck,et al.  Sodium-Calcium Exchange in Intracellular Calcium Handling of Human Airway Smooth Muscle , 2011, PloS one.

[14]  Kevin M. Curtis,et al.  Na‐K‐Cl cotransporter‐1 in the mechanism of cell swelling in cultured astrocytes after fluid percussion injury , 2011, Journal of neurochemistry.

[15]  Kevin M. Curtis,et al.  Aquaporin-4 expression in cultured astrocytes after fluid percussion injury. , 2011, Journal of neurotrauma.

[16]  F. Pashkow,et al.  Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model. , 2010, Thrombosis research.

[17]  J. Simard,et al.  Molecular mechanisms of microvascular failure in central nervous system injury--synergistic roles of NKCC1 and SUR1/TRPM4. , 2010, Journal of neurosurgery.

[18]  H. Sontheimer,et al.  Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 reduces glioma invasion. , 2010, Cancer research.

[19]  M. Norenberg,et al.  The Na–K–Cl Co-transporter in astrocyte swelling , 2010, Metabolic Brain Disease.

[20]  M. Yin,et al.  Antioxidative and anti-inflammatory neuroprotective effects of astaxanthin and canthaxanthin in nerve growth factor differentiated PC12 cells. , 2009, Journal of food science.

[21]  J. Coombes,et al.  Astaxanthin, oxidative stress, inflammation and cardiovascular disease. , 2009, Future cardiology.

[22]  Hui Shen,et al.  Astaxanthin reduces ischemic brain injury in adult rats , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  H. Ghofrani,et al.  A Functional Single-Nucleotide Polymorphism in the TRPC6 Gene Promoter Associated With Idiopathic Pulmonary Arterial Hypertension , 2009, Circulation.

[24]  A. Secondo,et al.  Anoxia-Induced NF-kB-Dependent Upregulation of NCX1 Contributes to Ca2+ Refilling Into Endoplasmic Reticulum in Cortical Neurons , 2009, Stroke.

[25]  G. Manley,et al.  Novel variants in human Aquaporin-4 reduce cellular water permeability. , 2008, Human molecular genetics.

[26]  M. Norenberg,et al.  Trauma-Induced Cell Swelling in Cultured Astrocytes , 2008, Journal of neuropathology and experimental neurology.

[27]  K. Lu,et al.  NKCC1-mediated traumatic brain injury-induced brain edema and neuron death via Raf/MEK/MAPK cascade , 2008, Critical care medicine.

[28]  Mei Liu,et al.  Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-κB and JNK activation and suppression of COX-2 activity , 2007, Journal of Neuroimmunology.

[29]  K. Lu,et al.  Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression , 2007, Neurological research.

[30]  G. Forloni,et al.  JNK signalling: a possible target to prevent neurodegeneration. , 2007, Current pharmaceutical design.

[31]  K. Lu,et al.  Inhibition of the Na+ -K+ -2Cl- -cotransporter in choroid plexus attenuates traumatic brain injury-induced brain edema and neuronal damage. , 2006, European journal of pharmacology.

[32]  J. Simard,et al.  Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic stroke , 2006, Nature Medicine.

[33]  D. Kintner,et al.  Na+-Dependent Chloride Transporter (NKCC1)-Null Mice Exhibit Less Gray and White Matter Damage after Focal Cerebral Ischemia , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  T. Joh,et al.  Transglutaminase 2 induces NF-κB activation via a novel pathway in BV-2 microglia , 2004 .

[35]  R. Raghupathi,et al.  Cell Death Mechanisms Following Traumatic Brain Injury , 2004, Brain pathology.

[36]  K. Ha,et al.  Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I ( kappa ) B kinase-dependent NF-kappaB activation , 2010 .

[37]  E. Mazzon,et al.  Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation , 2002, British journal of pharmacology.

[38]  R. Dempsey,et al.  Na+-K+-Cl− Cotransporter in Rat Focal Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  Y. Lee,et al.  Activation of Na(+), K(+), Cl(-)-cotransport mediates intracellular Ca(2+) increase and apoptosis induced by Pinacidil in HepG2 human hepatoblastoma cells. , 2001, Biochemical and biophysical research communications.

[40]  D. Graham,et al.  Apoptosis after traumatic brain injury. , 2000, Journal of neurotrauma.

[41]  S. Mandel,et al.  The Pivotal Role of Iron in NF‐κB Activation and Nigrostriatal Dopaminergic Neurodegeneration: Prospects for Neuroprotection in Parkinson's Disease with Iron Chelators , 1999, Annals of the New York Academy of Sciences.

[42]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[43]  J. Povlishock,et al.  A new model for rapid stretch-induced injury of cells in culture: characterization of the model using astrocytes. , 1995, Journal of neurotrauma.

[44]  N. Zambrano,et al.  Transcriptional regulation of ncx1 gene in the brain. , 2013, Advances in experimental medicine and biology.

[45]  G. Courtois,et al.  Mutations in the NF-kappaB signaling pathway: implications for human disease. , 2006, Oncogene.

[46]  Michael Karin,et al.  NF-kappaB: linking inflammation and immunity to cancer development and progression. , 2005, Nature reviews. Immunology.

[47]  A. Marmarou,et al.  Pathophysiology of traumatic brain edema: current concepts. , 2003, Acta neurochirurgica. Supplement.